Genistein promotes ionizing radiation-induced cell death by reducing cytoplasmic Bcl-xL levels in non-small cell lung cancer

被引:0
|
作者
Zhimin Zhang
Feng Jin
Xiaojuan Lian
Mengxia Li
Ge Wang
Baohua Lan
Hao He
Guo-Dong Liu
Yan Wu
Guiyin Sun
Cheng-Xiong Xu
Zhen-Zhou Yang
机构
[1] Third Military Medical University,Cancer Center, Daping Hospital and Research Institute of Surgery
[2] Jiangjin central hospital of Chongqing,Department of tumor blood
[3] Third Military Medical University,Eighth Department, Daping Hospital and Research Institute of Surgery
来源
Scientific Reports | / 8卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Genistein (GEN) has been previously reported to enhance the radiosensitivity of cancer cells; however, the detailed mechanisms remain unclear. Here, we report that GEN treatment inhibits the cytoplasmic distribution of Bcl-xL and increases nuclear Bcl-xL in non-small cell lung cancer (NSCLC). Interestingly, our in vitro data show that ionizing radiation IR treatment significantly increases IR-induced DNA damage and apoptosis in a low cytoplasmic Bcl-xL NSCLC cell line compared to that of high cytoplasmic Bcl-xL cell lines. In addition, clinical data also show that the level of cytoplasmic Bcl-xL was negatively associated with radiosensitivity in NSCLC. Furthermore, we demonstrated that GEN treatment enhanced the radiosensitivity of NSCLC cells partially due to increases in Beclin-1-mediated autophagy by promoting the dissociation of Bcl-xL and Beclin-1. Taken together, these findings suggest that GEN can significantly enhance radiosensitivity by increasing apoptosis and autophagy due to inhibition of cytoplasmic Bcl-xL distribution and the interaction of Bcl-xL and Beclin-1 in NSCLC cells, respectively.
引用
收藏
相关论文
共 50 条
  • [21] Sustained metaphase arrest in response to ionizing radiation in a non-small cell lung cancer cell line
    Kodym, Elisabeth
    Kodym, Reinhard
    Choy, Hak
    Saha, Debabrata
    RADIATION RESEARCH, 2008, 169 (01) : 46 - 58
  • [22] Crizotinib-induced immunogenic cell death in non-small cell lung cancer
    Peng Liu
    Liwei Zhao
    Jonathan Pol
    Sarah Levesque
    Adriana Petrazzuolo
    Christina Pfirschke
    Camilla Engblom
    Steffen Rickelt
    Takahiro Yamazaki
    Kristina Iribarren
    Laura Senovilla
    Lucillia Bezu
    Erika Vacchelli
    Valentina Sica
    Andréa Melis
    Tiffany Martin
    Lin Xia
    Heng Yang
    Qingqing Li
    Jinfeng Chen
    Sylvère Durand
    Fanny Aprahamian
    Deborah Lefevre
    Sophie Broutin
    Angelo Paci
    Amaury Bongers
    Veronique Minard-Colin
    Eric Tartour
    Laurence Zitvogel
    Lionel Apetoh
    Yuting Ma
    Mikael J. Pittet
    Oliver Kepp
    Guido Kroemer
    Nature Communications, 10
  • [23] Crizotinib-induced immunogenic cell death in non-small cell lung cancer
    Liu, Peng
    Zhao, Liwei
    Pol, Jonathan
    Levesque, Sarah
    Petrazzuolo, Adriana
    Pfirschke, Christina
    Engblom, Camilla
    Rickelt, Steffen
    Yamazaki, Takahiro
    Iribarren, Kristina
    Senovilla, Laura
    Bezu, Lucillia
    Vacchelli, Erika
    Sica, Valentina
    Melis, Andrea
    Martin, Tiffany
    Lin, Xia
    Yang, Heng
    Li, Qingqing
    Chen, Jinfeng
    Durand, Sylvere
    Aprahamian, Fanny
    Lefevre, Deborah
    Broutin, Sophie
    Paci, Angelo
    Bongers, Amaury
    Minard-Colin, Veronique
    Tartour, Eric
    Zitvogel, Laurence
    Apetoh, Lionel
    Ma, Yuting
    Pittet, Mikael J.
    Kepp, Oliver
    Kroemer, Guido
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [24] Targeting Bcl-2/Bcl-xl for small cell lung cancer treatment with LP-118
    Lee, Ling-Ling
    Chen, Huan
    Zhu, Cong
    Chen, Yao
    Feldmeier, Brianna
    Shen, Yue
    Chen, Yu
    Anthony, Stephen P.
    Tan, Fenlai
    Chen, Yi
    Dai, Bing
    CANCER RESEARCH, 2024, 84 (06)
  • [25] Apoptosis by gemcitabine in non-small cell lung cancer cell line KNS62 is induced downstream of caspase 8 and is profoundly blocked by Bcl-xL over-expression
    R. Kurdow
    B. Schniewind
    S. Zoefelt
    L. Boenicke
    A.-S. Boehle
    P. Dohrmann
    H. Kalthoff
    Langenbeck's Archives of Surgery, 2005, 390 : 243 - 248
  • [26] Apoptosis by gemcitabine in non-small cell lung cancer cell line KNS62 is induced downstream of caspase 8 and is profoundly blocked by Bcl-xL over-expression
    Kurdow, R
    Schniewind, B
    Zoefelt, S
    Boenicke, L
    Boehle, AS
    Dohrmann, P
    Kalthoff, H
    LANGENBECKS ARCHIVES OF SURGERY, 2005, 390 (03) : 243 - 248
  • [27] Targeting Bcl-XL enhances arsenic-induced cell death in ovarian cancer cells
    Tekedereli, Ibrahim
    Lopez-Berestein, Gabriel
    Ozpolat, Bulent
    CANCER RESEARCH, 2010, 70
  • [28] 18F-FLT PET/CT to guide therapy with EGFR antagonists and Bcl-xL inhibitors in non-small cell lung cancer
    Zannetti, A.
    Iommelli, F.
    Speranza, A.
    Salvatore, M.
    Del Vecchio, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S150 - S150
  • [29] Bcl-2, Bcl-xl, and pp32/PHAPI in Resected Non-Small-Cell Lung Cancer Patients
    Schmidt, L. H.
    Kuemmel, A.
    Schuler, M.
    Biesterfeld, S.
    Faldum, A.
    Taube, C.
    Buhl, R.
    Mueller-Tidow, C.
    Wiewrodt, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [30] Radiation-induced lymphopenia risk model predicts durvalumab benefit in non-small cell lung cancer
    van Rossum, P.
    Damen, P.
    Xu, T.
    Hobbs, B.
    Mohan, R.
    Liao, Z.
    Lin, S.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S113 - S114